Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
3 studies found for:    ((AT13387 AND GIST) OR NCT01245218 OR NCT00878423)
Show Display Options
Rank Status Study
1 Completed A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
Condition: Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: AT13387 and Imatinib
2 Completed Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors
Condition: Metastatic Solid Tumors
Intervention: Drug: AT13387
3 Completed AT13387 in Adults With Refractory Solid Tumors
Conditions: Solid Tumors;   Breast Cancer
Intervention: Drug: AT13387

Study has passed its completion date and status has not been verified in more than two years.